(JREU) JPMorgan s (Ireland) ICAV - Overview
Etf: Equity, Large-Cap, Mid-Cap, US, Index
| Risk 5d forecast | |
|---|---|
| Volatility | 14.0% |
| Relative Tail Risk | -4.66% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.11 |
| Alpha | -5.78 |
| Character TTM | |
|---|---|
| Beta | 0.219 |
| Beta Downside | 0.461 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.38% |
| CAGR/Max DD | 0.74 |
Description: JREU JPMorgan s (Ireland) ICAV January 29, 2026
The JPMorgan ETFs (Ireland) ICAV – US Research Enhanced Index Equity UCITS ETF (ticker JREU, listed on XETRA) tracks the Morningstar US Large-Mid NR USD index, offering exposure to a blend of large-cap U.S. equities while applying a proprietary research-enhancement overlay.
As of 30 September 2024, the fund holds roughly USD 1.2 billion in assets, charges an expense ratio of 0.15 % (net), and distributes earnings on an accumulating basis. Its top five holdings are Apple (≈5.6 %), Microsoft (≈5.2 %), Alphabet (≈4.8 %), Amazon (≈4.5 %) and Nvidia (≈3.9 %), together representing about 24 % of the portfolio. Sector weights are dominated by Information Technology (≈38 %) and Consumer Discretionary (≈18 %).
Key drivers for the ETF’s performance include the ongoing resilience of U.S. corporate earnings, the Federal Reserve’s stance on interest rates (the current policy-rate of 5.25-5.50 % influences discount rates for equity valuations), and sector-specific momentum in AI-related hardware and software firms, which have contributed to a year-to-date total return of roughly +9 % versus the S&P 500’s +7 %.
For a deeper, data-rich assessment of how JREU’s research overlay may affect risk-adjusted returns, you might explore the fund’s analytics on ValueRay.
What is the price of JREU shares?
Over the past week, the price has changed by +0.26%, over one month by -0.90%, over three months by +1.14% and over the past year by +0.64%.
Is JREU a buy, sell or hold?
What are the forecasts/targets for the JREU price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 66.1 | 13% |
JREU Fundamental Data Overview February 03, 2026
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 47.08b EUR (47.08b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 47.08b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 47.08b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 25.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.72% (E(47.08b)/V(47.08b) * Re(6.72%) + (debt-free company))
Discount Rate = 6.72% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)